Home › Immune System and Disorders › North Carolina › Greenville
Immune System and Disorders clinical trials in Greenville, NC
3 studies for Immune System and Disorders are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- East Carolina University, Greenville
- Marion L Shepard Cancer Center - ECU Health Beaufort Hospital, Washington · 18 mi away
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- East Carolina University, Greenville
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- East Carolina University, Greenville
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA10 studies
- Boston, MA10 studies
- Atlanta, GA9 studies
- Portland, OR9 studies
- Houston, TX9 studies
- Los Angeles, CA8 studies
- Chicago, IL8 studies
- Cleveland, OH8 studies
- Milwaukee, WI6 studies
- Seattle, WA6 studies
Other studies in Greenville
- Acute Myeloid Leukemia10 studies
- Sickle Cell Disease9 studies
- Idiopathic Thrombocytopenic Purpura6 studies
- Heart Failure6 studies
- Chronic Lymphocytic Leukemia5 studies
- Burkitt Lymphoma5 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Blood Disorders5 studies
- Cancer (all types)4 studies
- Autoimmune Diseases4 studies
- Myeloproliferative Neoplasms4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.